AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Genes & Diseases Article
PDF (1.1 MB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Rapid Communication | Open Access

Prevention and treatment of gerbil hepatitis E using the programmable CRISPR-Cas13d system

Chengcheng Zhaoa, Chong Lia, Sa Lia, Hanyu Wua, Pengyao Rena, Tianlong Liub( ), Xiaoxiang Hua, Ran Zhanga( )
State Key Laboratory of Animal Biotech Breeding, College of Biological Sciences, China Agricultural University, Beijing 100193, China
Laboratory of Veterinary Pathology and Nanopathology, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China

Peer review under responsibility of Chongqing Medical University.

Show Author Information

References

【1】
【1】
 
 
Crossref Google Scholar
Genes & Diseases
Volume 11 Issue 4,
July 2024
Article number: 101051
DOI: 10.1016/j.gendis.2023.06.020

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Cite this Report
Close
Close
Cite this article:
Zhao C, Li C, Li S, et al. Prevention and treatment of gerbil hepatitis E using the programmable CRISPR-Cas13d system. Genes & Diseases, 2024, 11(4): 101051. https://doi.org/10.1016/j.gendis.2023.06.020

619

Views

7

Downloads

1

Crossref

2

Web of Science

2

Scopus

0

CSCD
Received: 29 March 2023
Published: 24 July 2023
© 2023 The Authors.

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).